Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.54 |
| ▸ | CTSL | P07711 | 9/20 | 0.51 |
| ▸ | KYNU | Q16719 | 1/20 | 0.50 |
| ▸ | CTSB | P07858 | 2/20 | 0.49 |
| ▸ | ATM | Q13315 | 2/20 | 0.49 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | CASP1 | P29466 | 1/20 | 0.47 |
| ▸ | CTSK | P43235 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3331611 | 0.86 | TRPM8 (0.67) | TRPM8CTSLKYNUCTSBATM | |
| SCHEMBL25271394 | 0.85 | TRPM8 (0.55) | TRPM8KYNUATMCTRB1ALDH1A1 | |
| SCHEMBL25222634 | 0.85 | TRPM8 (0.55) | TRPM8KYNUATMCTRB1ALDH1A1 | |
| SCHEMBL25224988 | 0.85 | TRPM8 (0.55) | TRPM8KYNUATMCTRB1ALDH1A1 | |
| SCHEMBL3333284 | 0.84 | CTSK (0.60) | TRPM8CTSLCTSBATMCTSK | |
| SCHEMBL30484725 | 0.84 | TRPM8 (0.49) | TRPM8CTSLKYNUCTSBATM | |
| SCHEMBL13536987 | 0.81 | CTSL (0.54) | TRPM8CTSLCTSBATMCTRB1 | |
| SCHEMBL1701841 | 0.81 | CTSL (0.51) | TRPM8CTSLCTSBATMCTRB1 | |
| SCHEMBL8100463 | 0.81 | CTSL (0.51) | TRPM8CTSLCTSBATMCTRB1 | |
| SCHEMBL8100330 | 0.81 | CTSL (0.51) | TRPM8CTSLCTSBATMCTRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2137139-B1 | PROCESS OF DEACETALISATION OF ALPHA AMINOACETALS | CLARIANT SPECIALTY FINE CHEM (FR) | 2014-09-10 | — | — | EP | disclosed |
| CN-101679223-B | Deacetalization of alpha aminoacetals | CLARIANT SPECIALTY FINE CHEM | 2014-04-16 | — | — | CN | disclosed |
| US-8609882-B2 | Process for deacetalisation of α aminoacetals | CLARIANT SPECIALITY FINE CHEMICALS (FRANCE) (FR) | 2013-12-17 | — | — | US | disclosed |
| US-20100137633-A1 | Process For Deacetalisation Of Alpha Aminoacetals | CLARIANT SPECIALTY FINE CHEMICALS (FRANCE) (FR) | 2010-06-03 | — | — | US | disclosed |
| CN-101679223-A | Deacetalization of alpha aminoacetals | CLARIANT SPECIALTY FINE CHEM | 2010-03-24 | — | — | CN | disclosed |
| EP-2137139-A1 | PROCESS OF DEACETALISATION OF ALPHA AMINOACETALS | Clariant Specialty Fine Chemicals (France) (FR) | 2009-12-30 | — | — | EP | disclosed |
| WO-2008125486-A1 | PROCESS OF DEACETALISATION OF ALPHA AMINOACETALS | CLARIANT SPECIALTY FINE CHEMICALS (FRANCE) (FR) | 2008-10-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100137633-A1 | Process For Deacetalisation Of Alpha Aminoacetals | ALDH7A1, AADAT, AASDHPPT | TRPM8 4702/4885CTSL 1941/4885KYNU 87/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.